Suchergebnisse
Suchergebnisse:
Tasuku Honjo ist ein japanischer Immunologe, der für Forschungen über die molekularbiologischen Ursachen der Antikörper-Diversität und neue immunologische Ansätze in der Krebstherapie bekannt ist. 2018 wurde ihm zusammen mit James P. Allison der Nobelpreis für Physiologie oder Medizin zuerkannt.
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942) is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1).
Tasuku Honjo is a Japanese immunologist who discovered a protein that inhibits the immune system. He shared the Nobel Prize in Physiology or Medicine 2018 with James Allison for their discovery of cancer therapy by inhibition of negative immune regulation.
Learn about the life and work of Tasuku Honjo, who discovered the protein PD-1 and its role in immunotherapy. Read his biography, from his childhood in wartime Japan to his breakthrough discoveries in molecular biology and cancer research.
1. Okt. 2018 · Tasuku Honjo discovered PD-1, a protein that functions as a brake on T cells, and developed it into a new strategy for cancer therapy. He shared the Nobel Prize in Physiology or Medicine with James P. Allison, who discovered CTLA-4, another T-cell brake.
Tasuku Honjo is a distinguished professor and deputy director-general of KUIAS, and a Nobel laureate in medicine for his discovery of PD-1. He has also made significant contributions to molecular immunology, class switch recombination, and cancer immunotherapy.
1. Okt. 2018 · Von einer Revolution in der Krebsbehandlung spricht die Nobel-Jury: Der US-Amerikaner James Patrick Allison und der Japaner Tasuku Honjo haben erforscht, wie das Immunsystem gegen Krebs scharf...
